ENDRA Life Sciences Inc (NDRA) USD0.0001

Sell:$3.86Buy:$4.44$0.18 (4.39%)

Prices delayed by at least 15 minutes
Sell:$3.86
Buy:$4.44
Change:$0.18 (4.39%)
Prices delayed by at least 15 minutes
Sell:$3.86
Buy:$4.44
Change:$0.18 (4.39%)
Prices delayed by at least 15 minutes

Company Information

About this company

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. It is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Key people

Alexander Y. Tokman
Chairman of the Board, Acting Chief Executive Officer
Richard Jacroux
Chief Financial Officer
Michael Milos Thornton
Chief Technology Officer
Louis J. Basenese
Independent Director
Anthony DiGiandomenico
Independent Director
Michael John Harsh
Independent Director
Click to see more

Key facts

  • EPIC
    NDRA
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US29273B5003
  • Market cap
    $2.17m
  • Employees
    21
  • Shares in issue
    536,908.00
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.